title: [Coronary insufficiency after an oral intake of capecitabine].
authors.forename: J
authors.initials: J
authors.lastname: Desramé
authors.forename: J A
authors.initials: JA
authors.lastname: Bronstein
authors.forename: C
authors.initials: C
authors.lastname: Thiolet
authors.forename: C
authors.initials: C
authors.lastname: Bredin
authors.forename: B
authors.initials: B
authors.lastname: Ceccaldi
authors.forename: B
authors.initials: B
authors.lastname: Vergeau
authors.forename: O
authors.initials: O
authors.lastname: Farret
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil